Chancery Sends Innoviva Board Fight With Sarissa To Trial
A Delaware Chancery judge ruled Wednesday that the dispute over biotech licensing firm Innoviva Inc.'s board makeup and whether activist hedge fund Sarissa Capital Management LP can have two director seats...To view the full article, register now.
Already a subscriber? Click here to view full article